U.S. Markets close in 5 hrs 13 mins

Amarin Corporation plc (AMRN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.2634+0.0134 (+0.4123%)
As of 10:47AM EDT. Market open.
People also watch
ARNAACHNOREXGALEVVUS
Full screen
Previous Close3.2500
Open3.2800
Bid3.2400 x 3100
Ask3.2500 x 1700
Day's Range3.2400 - 3.2950
52 Week Range2.5700 - 4.4700
Volume248,394
Avg. Volume2,675,645
Market Cap883.7M
Beta1.88
PE Ratio (TTM)-10.46
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube8 days ago

    ETFs with exposure to Amarin Corp. Plc : September 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Amarin Corp. Plc Here are 5 ETFs with the largest exposure to AMRN-US. Comparing the performance and risk of Amarin Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube19 days ago

    ETFs with exposure to Amarin Corp. Plc : August 31, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Amarin Corp. Plc Here are 5 ETFs with the largest exposure to AMRN-US. Comparing the performance and risk of Amarin Corp. Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cube25 days ago

    Amarin Corp. Plc :AMRN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis Amarin Corp. Plc reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Amarin Corp. Plc – Ionis Pharmaceuticals, Inc., AbbVie, Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Neptune Technologies & Bioressources Inc., Alkermes Plc and Astrazeneca ... Read more (Read more...)